Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Cytotoxic Drugs Market Research Report 2019-2025

Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Cytotoxic Drugs Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Alkylating Agents
      • 1.3.3 Antitumor Antibiotics
      • 1.3.4 Antimetabolites
      • 1.3.5 Plant Alkaloids
      • 1.3.6 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Cytotoxic Drugs Market Share by Application (2019-2025)
      • 1.4.2 Hospital
      • 1.4.3 Cancer Research Center
      • 1.4.4 Drug Testing Laboratory
      • 1.4.5 CDMOs
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Cytotoxic Drugs Market Size
      • 2.1.1 Global Cytotoxic Drugs Revenue 2014-2025
      • 2.1.2 Global Cytotoxic Drugs Sales 2014-2025
    • 2.2 Cytotoxic Drugs Growth Rate by Regions
      • 2.2.1 Global Cytotoxic Drugs Sales by Regions 2014-2019
      • 2.2.2 Global Cytotoxic Drugs Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Cytotoxic Drugs Sales by Manufacturers
      • 3.1.1 Cytotoxic Drugs Sales by Manufacturers 2014-2019
      • 3.1.2 Cytotoxic Drugs Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Cytotoxic Drugs Revenue by Manufacturers (2014-2019)
      • 3.2.2 Cytotoxic Drugs Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Cytotoxic Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.3 Cytotoxic Drugs Price by Manufacturers
    • 3.4 Key Manufacturers Cytotoxic Drugs Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Cytotoxic Drugs Market
    • 3.6 Key Manufacturers Cytotoxic Drugs Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Alkylating Agents Sales and Revenue (2014-2019)
      • 4.1.2 Antitumor Antibiotics Sales and Revenue (2014-2019)
      • 4.1.3 Antimetabolites Sales and Revenue (2014-2019)
      • 4.1.4 Plant Alkaloids Sales and Revenue (2014-2019)
      • 4.1.5 Others Sales and Revenue (2014-2019)
    • 4.2 Global Cytotoxic Drugs Sales Market Share by Type
    • 4.3 Global Cytotoxic Drugs Revenue Market Share by Type
    • 4.4 Cytotoxic Drugs Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Cytotoxic Drugs Sales by Application

    6 United States

    • 6.1 United States Cytotoxic Drugs Breakdown Data by Company
    • 6.2 United States Cytotoxic Drugs Breakdown Data by Type
    • 6.3 United States Cytotoxic Drugs Breakdown Data by Application

    7 European Union

    • 7.1 European Union Cytotoxic Drugs Breakdown Data by Company
    • 7.2 European Union Cytotoxic Drugs Breakdown Data by Type
    • 7.3 European Union Cytotoxic Drugs Breakdown Data by Application

    8 China

    • 8.1 China Cytotoxic Drugs Breakdown Data by Company
    • 8.2 China Cytotoxic Drugs Breakdown Data by Type
    • 8.3 China Cytotoxic Drugs Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Cytotoxic Drugs Breakdown Data by Company
    • 9.2 Rest of World Cytotoxic Drugs Breakdown Data by Type
    • 9.3 Rest of World Cytotoxic Drugs Breakdown Data by Application
    • 9.4 Rest of World Cytotoxic Drugs Breakdown Data by Countries
      • 9.4.1 Rest of World Cytotoxic Drugs Sales by Countries
      • 9.4.2 Rest of World Cytotoxic Drugs Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 CytoPharma
      • 10.1.1 CytoPharma Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Cytotoxic Drugs
      • 10.1.4 Cytotoxic Drugs Product Introduction
      • 10.1.5 CytoPharma Recent Development
    • 10.2 Bristol-Myers Squibb
      • 10.2.1 Bristol-Myers Squibb Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Cytotoxic Drugs
      • 10.2.4 Cytotoxic Drugs Product Introduction
      • 10.2.5 Bristol-Myers Squibb Recent Development
    • 10.3 Amgen
      • 10.3.1 Amgen Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Cytotoxic Drugs
      • 10.3.4 Cytotoxic Drugs Product Introduction
      • 10.3.5 Amgen Recent Development
    • 10.4 Celgene Corp
      • 10.4.1 Celgene Corp Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Cytotoxic Drugs
      • 10.4.4 Cytotoxic Drugs Product Introduction
      • 10.4.5 Celgene Corp Recent Development
    • 10.5 Eli Lilly and Company
      • 10.5.1 Eli Lilly and Company Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Cytotoxic Drugs
      • 10.5.4 Cytotoxic Drugs Product Introduction
      • 10.5.5 Eli Lilly and Company Recent Development
    • 10.6 F. Hoffmann-La Roche
      • 10.6.1 F. Hoffmann-La Roche Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Cytotoxic Drugs
      • 10.6.4 Cytotoxic Drugs Product Introduction
      • 10.6.5 F. Hoffmann-La Roche Recent Development
    • 10.7 GlaxoSmithKline PLC
      • 10.7.1 GlaxoSmithKline PLC Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Cytotoxic Drugs
      • 10.7.4 Cytotoxic Drugs Product Introduction
      • 10.7.5 GlaxoSmithKline PLC Recent Development
    • 10.8 Johnson and Johnson
      • 10.8.1 Johnson and Johnson Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Cytotoxic Drugs
      • 10.8.4 Cytotoxic Drugs Product Introduction
      • 10.8.5 Johnson and Johnson Recent Development
    • 10.9 Lonza
      • 10.9.1 Lonza Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Cytotoxic Drugs
      • 10.9.4 Cytotoxic Drugs Product Introduction
      • 10.9.5 Lonza Recent Development
    • 10.10 Merck
      • 10.10.1 Merck Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Cytotoxic Drugs
      • 10.10.4 Cytotoxic Drugs Product Introduction
      • 10.10.5 Merck Recent Development
    • 10.11 Novartis
    • 10.12 Pfizer
    • 10.13 Sanofi
    • 10.14 Teva Pharmaceutical

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Cytotoxic Drugs Sales Channels
      • 11.2.2 Cytotoxic Drugs Distributors
    • 11.3 Cytotoxic Drugs Customers

    12 Market Forecast

    • 12.1 Global Cytotoxic Drugs Sales and Revenue Forecast 2019-2025
    • 12.2 Global Cytotoxic Drugs Sales Forecast by Type
    • 12.3 Global Cytotoxic Drugs Sales Forecast by Application
    • 12.4 Cytotoxic Drugs Forecast by Regions
      • 12.4.1 Global Cytotoxic Drugs Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Cytotoxic Drugs Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Cytotoxic drugs are being used as a potent drug in cancer treatment. Cytotoxic drugs are also used in developing ADCs (antibody-drug conjugates): There are two types of cytotoxic agents available currently, one is DNA modifying agents and the other is microtubule disrupting agents which effects the cell cycle in order restrict them to multiply and unlike drugs of category which are cell life cycle specific, DNA modifying agents kill cells at any point. Cytotoxic Drugs included in the report are products that are used for cancer treatment and research.
      In the drug type category for cytotoxic drugs, antimetabolites is the leading segment with most of the market share by value and volume.
      In 2019, the market size of Cytotoxic Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Cytotoxic Drugs.

      This report studies the global market size of Cytotoxic Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Cytotoxic Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      CytoPharma
      Bristol-Myers Squibb
      Amgen
      Celgene Corp
      Eli Lilly and Company
      F. Hoffmann-La Roche
      GlaxoSmithKline PLC
      Johnson and Johnson
      Lonza
      Merck
      Novartis
      Pfizer
      Sanofi
      Teva Pharmaceutical

      Market Segment by Product Type
      Alkylating Agents
      Antitumor Antibiotics
      Antimetabolites
      Plant Alkaloids
      Others

      Market Segment by Application
      Hospital
      Cancer Research Center
      Drug Testing Laboratory
      CDMOs

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Cytotoxic Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Cytotoxic Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Cytotoxic Drugs are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now